During the past decade, Lynn Institute of Denver conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lynn Institute of Denver" #1 sponsor was "Pfizer" with 4 trials, followed by "BioNTech SE" with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored, "Arena Pharmaceuticals" with 1 trials sponsored and "AstraZeneca" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lynn Institute of Denver" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Lynn Institute of Denver" are "COVID-19" (2 trials), "Cardiovascular Disease" (2 trials), "Chronic Idiopathic Constipation" (2 trials), "Overactive Bladder" (2 trials) and "SARS-CoV-2 Infection" (2 trials). Many other conditions were trialed in "Lynn Institute of Denver" in a lesser frequency.

Most popular intervention types in "Lynn Institute of Denver" are "Drug" (13 trials), "Biological" (5 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "BNT162b2" (2 trials), "Tolterodine Tartrate ER" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "BNT162b1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lynn Institute of Denver" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Lynn Institute of Denver". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Lynn Institute of Denver, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lynn Institute of Denver, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".